3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
3
Completed
3
Unknown
1
Sponsor Class
OTHER
38
OTHER_GOV
3
INDUSTRY
2
NETWORK
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Breast Neoplasms
45
Neoplasms
28
Uterine Cervical Neoplasms
24
Carcinoma, Non-Small-Cell Lung
22
Prostatic Neoplasms
20
Stomach Neoplasms
18
Colorectal Neoplasms
18
Carcinoma, Hepatocellular
16
Multiple Myeloma
14
Ovarian Neoplasms
11
Recurrence
10
Pancreatic Neoplasms
10
Esophageal Squamous Cell Carcinoma
10
Esophageal Neoplasms
9
Leukemia, Myeloid, Acute
8
Endometrial Neoplasms
8
Lymphoma
7
Lung Neoplasms
7
Brain Neoplasms
7
Liver Neoplasms
6
Leukemia
6
Disease
6
Carcinoma, Ovarian Epithelial
6
Triple Negative Breast Neoplasms
5
Small Cell Lung Carcinoma
5
Rectal Neoplasms
5
Papillomavirus Infections
5
Melanoma
5
Colonic Neoplasms
5
Urinary Bladder Neoplasms
4
Interventions
lithium sulfate
1
fasudil
1
Radiotherapy
1
Lithium
1
Drug Therapy
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER_GOV
×
Cognitive Dysfunction
×
Clear all
NCT06362707
2026-05-04
FEAD
Helse Stavanger HF
Phase 2
Recruiting
200 enrolled
NCT06551857
2025-04-16
CaSPiN
Turku University Hospital
Recruiting
250 enrolled
NCT06051240
2024-04-12
LiBRA
Region Stockholm
Phase 2
Recruiting
84 enrolled